198 Results

People

  1. Kelsen
    Kelsen
  2. Saltz
    Saltz
  3. Spriggs
    Spriggs
  4. Tong
    Tong
  5. Seidman
    Seidman
  6. Scher
    Scher
  7. Hudis
    Hudis
  8. Kemeny
    Kemeny
  9. Norton
    Norton
  10. Ilson
    Ilson

Groups

  1. Department of Medicine (112)
  2. Solid Tumor Oncology Division (99)
  3. Surgery (35)
  4. Gastrointestinal Oncology Service (33)
  5. Survivorship Research (27)
  6. Sloan Kettering Institute Faculty (26)
  7. Center for Pancreatic Cancer Research (24)
  8. Genitourinary Oncology Service (24)
  9. Molecular Pharmacology and Chemistry Program Faculty (24)
  10. Breast Medicine Service (23)
  1. "infusions, intravenous"
Formats
  1. Journal Article (192)
  2. Conference Paper (5)
  3. Meeting Abstract (1)
Groups
  1. Department of Medicine (112)
  2. Solid Tumor Oncology Division (99)
  3. Surgery (35)
  4. Gastrointestinal Oncology Service (33)
  5. Survivorship Research (27)
  6. Sloan Kettering Institute Faculty (26)

More Groups

People
  1. David Kelsen (16)
  2. Leonard Saltz (15)
  3. Nancy Kemeny (15)
  4. David Spriggs (14)
  5. William Tong (14)
  6. Andrew Seidman (13)

More People

Years
  1. 2023 (1)
  2. 2022 (1)
  3. 2021 (1)
  4. 2019 (1)
  5. 2018 (2)
  6. 2017 (1)

More Years

Publications
  1. Journal of Clinical Oncology (34)
  2. Cancer (23)
  3. Investigational New Drugs (15)
  4. Clinical Cancer Research (9)
  5. Gynecologic Oncology (8)
  6. Cancer Chemotherapy and Pharmacology (5)

More Publications

Publishers
  1. American Society of Clinical Oncology (34)
  2. Wiley Blackwell (28)
  3. Springer (26)
  4. Elsevier Inc. (23)
  5. Lippincott Williams & Wilkins (15)
  6. American Association for Cancer Research (14)

More Publishers

Results (198)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Population analysis of a 24-h paclitaxel infusion in advanced endometrial cancer: A gynaecological oncology group study
    Journal Article

    Mould, D. R.; Fleming, G. F.; Darcy, K. M.; Spriggs, D.
    British Journal of Clinical Pharmacology (2006)

    Fulltext@MSK | Save
  • A phase I study of cetuximab in combination with paclitaxel in patients with advanced-stage breast cancer
    Journal Article

    Modi, S.; D'Andrea, G.; Norton, L.; Yao, T. J.; Caravelli, J.; Rosen, P. P.; Hudis, C.; Seidman, A. D.
    Clinical Breast Cancer (2006)

    Fulltext@MSK | Save
  • Systemic high-dose intravenous methotrexate for central nervous system metastases
    Journal Article

    Lassman, A. B.; Abrey, L. E.; Shah, G. D.; Panageas, K. S.; Begemann, M.; Malkin, M. G.; Raizer, J. J.
    Journal of Neuro-Oncology (2006)

    Fulltext@MSK | Save
  • Busulfan pharmacokinetics, toxicity, and low-dose conditioning for autologous transplantation of genetically modified hematopoietic stem cells in the rhesus macaque model
    Journal Article

    Kang, E. M.; Hsieh, M. M.; Metzger, M.; Krouse, A.; Donahue, R. E.; Sadelain, M.; Tisdale, J. F.
    Experimental Hematology (2006)

    Fulltext@MSK | Save
  • Pharmacokinetics, biodistribution, and antitumor efficacy of a human glandular kallikrein 2 (hK2)-activated thapsigargin prodrug
    Journal Article

    Janssen, S.; Rosen, D. M.; Ricklis, R. M.; Dionne, C. A.; Lilja, H.; Christensen, S. B.; Isaacs, J. T.; Denmeade, S. R.
    Prostate (2006)

    Fulltext@MSK | Save
  • A phase II clinical and pharmacodynamic study of temsirolimus in advanced neuroendocrine carcinomas
    Journal Article

    Duran, I.; Kortmansky, J.; Singh, D.; Hirte, H.; Kocha, W.; Goss, G.; Le, L.; Oza, A.; Nicklee, T.; Ho, J.; more...
    British Journal of Cancer (2006)

    Fulltext@MSK | Save
  • Safety and biologic activity of intravenous BCL-2 antisense oligonucleotide (G3139) and taxane chemotherapy in patients with advanced cancer
    Journal Article

    Morris, M. J.; Cordon-Cardo, C.; Kelly, W. K.; Slovin, S. F.; Siedlecki, K.; Regan, K. P.; DiPaola, R. S.; Rafi, M.; Rosen, N.; Scher, H. I.
    Applied Immunohistochemistry & Molecular Morphology (2005)

    Fulltext@MSK | Save
  • A phase II trial of gemcitabine in patients with metastatic breast cancer previously treated with an anthracycline and taxane
    Journal Article

    Modi, S.; Currie, V. E.; Seidman, A. D.; Bach, A. M.; Panageas, K. S.; Theodoulou, M.; Moasser, M. M.; D'Andrea, G. M.; Lake, D. E.; Choi, J.; more...
    Clinical Breast Cancer (2005)

    Fulltext@MSK | Save
  • Five-day courses of irinotecan as palliative therapy for patients with neuroblastoma
    Journal Article

    Kushner, B. H.; Kramer, K.; Modak, S.; Cheung, N. K. V.
    Cancer (2005)

    Fulltext@MSK | Save
  • Multi-institutional phase 2 study of TLK286 (TELCYTA™, a glutathione S-transferase P1-1 activated glutathione analog prodrug) in patients with platinum and paclitaxel refractory or resistant ovarian cancer
    Journal Article

    Kavanagh, J. J.; Gershenson, D. M.; Choi, H.; Lewis, L.; Patel, K.; Brown, G. L.; Garcia, A.; Spriggs, D. R.
    International Journal of Gynecological Cancer (2005)

    Fulltext@MSK | Save